PCV94 THE COST-EFFECTIVENESS OF TITRATION TO GOAL WITH BRAND ROSUVASTATIN COMPARED TO GENERIC SIMVASTATIN IN PATIENTS WITH ELEVATED LOW-DENSITY LIPOPROTEIN CHOLESTEROL- PRIMARY AND SECONDARY PREVENTION IN THE BELGIAN HEALTH CARE SETTING

Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74621-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)74621-0/fulltext
Title : PCV94 THE COST-EFFECTIVENESS OF TITRATION TO GOAL WITH BRAND ROSUVASTATIN COMPARED TO GENERIC SIMVASTATIN IN PATIENTS WITH ELEVATED LOW-DENSITY LIPOPROTEIN CHOLESTEROL- PRIMARY AND SECONDARY PREVENTION IN THE BELGIAN HEALTH CARE SETTING
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74621-0&doi=10.1016/S1098-3015(10)74621-0
First page :
Section Title :
Open access? : No
Section Order : 1
Categories :
Tags :
Regions :
ViH Article Tags :